Citation Impact
Citing Papers
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
2018 StandoutScienceNobel
Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes
2006 StandoutScience
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
2007 StandoutScience
Biochemical and Clinical Implications of the ErbB/HER Signaling Network of Growth Factor Receptors
1999
Regulation of Angiogenesis by Oxygen and Metabolism
2009
Hallmarks of Cancer: The Next Generation
2011 Standout
Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene
1997
Involvement of Members of the Cadherin Superfamily in Cancer
2009
Rat liver sinusoidal endothelial cell phenotype is maintained by paracrine and autocrine regulation
2004
Vascularized and functional human liver from an iPSC-derived organ bud transplant
2013 StandoutNature
Direct Infection and Replication of Naturally Occurring Hepatitis C Virus Genotypes 1, 2, 3 and 4 in Normal Human Hepatocyte Cultures
2008
T-cell-receptor gene therapy
2002
Imaging in the era of molecular oncology
2008 StandoutNature
Ranibizumab for Neovascular Age-Related Macular Degeneration
2006 Standout
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
2004 Standout
Functional interactions between Stat5 and the glucocorticoid receptor
1996 Nature
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
2006 Standout
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Expression of Vascular Endothelial Growth Factor Receptor 1 in Bone Marrow-derived Mesenchymal Cells Is Dependent on Hypoxia-inducible Factor 1
2006 StandoutNobel
The biology of VEGF and its receptors
2003 Standout
A New Weapon for Attacking Tumor Blood Vessels
2008 StandoutNobel
Immunotherapy through TCR gene transfer
2001
Ten years of anti-vascular endothelial growth factor therapy
2016
Targeting tumours with genetically enhanced T lymphocytes
2003
Endothelial cells and VEGF in vascular development
2005 Nature
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
2011 Standout
Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration
2010 Nature
Angiogenesis in life, disease and medicine
2005 StandoutNature
IL‐1, IL‐18, and IL‐33 families of cytokines
2008
Transcriptional Inhibition by Stat5
1997
Modulation of protein structure and function by asparagine-linked glycosylation
1996
EMT: 2016
2016 Standout
Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone
2014 StandoutNature
Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids
2018 StandoutNobel
Angiocrine functions of organ-specific endothelial cells
2016 Nature
Capturing complex 3D tissue physiology in vitro
2006 Standout
Liver regeneration: from myth to mechanism
2004
Micropatterning of living cells by laser-guided direct writing: application to fabrication of hepatic–endothelial sinusoid-like structures
2006
Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells
2009 StandoutNature
Genetic dissection of tumor angiogenesis: are PlGF and VEGFR-1 novel anti-cancer targets?
2003
Myeloid Lineage Commitment from the Hematopoietic Stem Cell
2007
AKT/PKB Signaling: Navigating the Network
2017 Standout
The promise and potential pitfalls of chimeric antigen receptors
2009
Endothelium-Microenvironment Interactions in the Developing Embryo and in the Adult
2007
Liver Regeneration after Partial Hepatectomy
2009
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity
2010 StandoutNature
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
2004 Standout
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
2010 StandoutNature
Vascular endothelial growth factor receptor‐1 promotes migration and invasion in pancreatic carcinoma cell lines
2005
Multiple Stat complexes interact at the interferon regulatory factor-1 interferon-γ activation sequence in prolactin-stimulated Nb2 T cells
1996
Angiogenesis as a therapeutic target
2005 StandoutNature
Developmental and Pathological Angiogenesis
2011
Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptor
2002
VEGF and Intraocular Neovascularization: From Discovery to Therapy
2016
Organogenesis and Development of the Liver
2010
IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated Cytokines
2005 Standout
Targeting the tumour vasculature: insights from physiological angiogenesis
2010
LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling
2013 StandoutNature
Multiple Prolactin (PRL) Receptor Cytoplasmic Residues and Stat1 Mediate PRL Signaling to the Interferon Regulatory Factor-1 Promoter
1997
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
2018 Standout
The Absence of Interleukin 1 Receptor–Related T1/St2 Does Not Affect T Helper Cell Type 2 Development and Its Effector Function
1999
A Strategy for the Chemoselective Synthesis of O-Linked Glycopeptides with Native Sugar−Peptide Linkages
1997 StandoutNobel
Interactions among Janus kinases and the prolactin (PRL) receptor in the regulation of a PRL response element.
1996
Directed and Systematic Differentiation of Cardiovascular Cells From Mouse Induced Pluripotent Stem Cells
2008 StandoutNobel
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Immuno-Navigator, a batch-corrected coexpression database, reveals cell type-specific gene networks in the immune system
2016 StandoutNobel
VEGF and its receptors
2004
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
STATs and Gene Regulation
1997 StandoutScience
Activation of Stat5a and Stat5b by tyrosine phosphorylation is tightly linked to mammary gland differentiation.
1996
Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice
1998 Standout
Programmed assembly of 3-dimensional microtissues with defined cellular connectivity
2009 StandoutNobel
Crystal structure of Toll-like receptor adaptor MAL/TIRAP reveals the molecular basis for signal transduction and disease protection
2011 StandoutNobel
Immunological and Inflammatory Functions of the Interleukin-1 Family
2009 Standout
Two Functionally Distinct Subsets of Mast Cells Discriminated By IL-2–Independent CD25 Activities
2014
Phosphoproteomic Analysis Implicates the mTORC2-FoxO1 Axis in VEGF Signaling and Feedback Activation of Receptor Tyrosine Kinases
2013
Intracellular Functions of N-Linked Glycans
2001 StandoutScience
Cancer Genome Landscapes
2013 StandoutScience
Endothelial Hypoxia-Inducible Factor-2α Is Required for the Maintenance of Airway Microvasculature
2019 StandoutNobel
Expression of a functional VEGFR-1 in tumor cells is a major determinant of anti-PlGF antibodies efficacy
2011
Proenkephalin+regulatory T cells expanded by ultraviolet B exposure maintain skin homeostasis with a healing function
2020 StandoutNobel
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
Deletion of the Carboxyl-Terminal Transactivation Domain of MGF-Stat5 Results in Sustained DNA Binding and a Dominant Negative Phenotype
1996
Preparing the “Soil”: The Premetastatic Niche
2006
Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures
2010 StandoutNobel
Developmental checkpoints of the basophil/mast cell lineages in adult murine hematopoiesis
2005
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
JNK1 controls mast cell degranulation and IL-1β production in inflammatory arthritis
2010 StandoutNobel
Works of Dirk Moritz being referenced
Expression Analysis of the Soluble and Membrane-Associated Forms of the Interleukin-1 Receptor-Related Tl Protein in Primary Mast Cells and Fibroblasts
1998
Cytolysis of tumor cells expressing the Neu/erbB-2, erbB-3, and erbB-4 receptors by genetically targeted naive T lymphocytes.
1996
Angiogenesis-Independent Endothelial Protection of Liver: Role of VEGFR-1
2003 Science
Specific cytotoxic T lymphocytes in gene therapy
1997
Mutation of conserved N-glycosylation sites around the CD4-binding site of human immunodeficiency virus type 1 GP120 affects viral infectivity
1990
Growth retardation of tumors by adoptive transfer of cytotoxic T lymphocytes reprogrammed by CD44V6-specific SCFV: ζ-chimera
1996
Cytotoxic T lymphocytes with a grafted recognition specificity for ERBB2-expressing tumor cells.
1994
Prolactin and interleukin-2 receptors in T lymphocytes signal through a MGF-STAT5-like transcription factor.
1995
The IL-1 Receptor-Related T1 Antigen Is Expressed on Immature and Mature Mast Cells and on Fetal Blood Mast Cell Progenitors
1998
A spacer region between the single chain antibody- and the CD3 zeta-chain domain of chimeric T cell receptor components is required for efficient ligand binding and signaling activity.
1995
Increased expression of H/T-cadherin in tumor-penetrating blood vessels.
2000